Clinical Decision Support Tools for Antibiotic Prescribing

NCT03580603 | Completed

• 1 other identifier: 2017P000432
• Study Type: interventional
• Target: 273
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this study is to assess the utility of a data visualization tool for providers' understanding patients' past microbiological culture sensitivities. Providers that are ordering antibiotics for patients with previous culture data in the medical record will be asked to answer questions regarding past sensitivity results. They will be randomized to either using the visualization tool before answering the questions or using the standard medical record tools. They will then be surveyed about their decision-making, knowledge, and the usefulness of the tool.

Conditions

Infectious Disease

Outcome Measures

Primary Outcomes (1)

• Provider knowledge

  Provider knowledge of patients' previous culture sensitivity results as determined by the proportion of correct answers on a questionnaire: Do you think this patient has had previous resistance to each of these antibiotics at BIDMC (Beth Israel Deaconess Medical Center)? \[List of the top 4 antibiotic classes to which resistance is seen at BIDMC that the patient has previously had tested for antibiotic sensitivities\] Yes (previous organisms resistant or with intermediate resistance) No (no previous resistance noted)

  To be assessed at the time of patient enrollment, up to one day after the initial antibiotic is ordered.

Secondary Outcomes (3)

• Post-intervention survey

  To be assessed at the time of patient enrollment, up to one day after the initial antibiotic is ordered.

• Antibiotic order changes

  To be assessed at the time of patient enrollment + 1 day

• Final culture results

  To be assessed at the time of patient enrollment + 1 week

Study Arms (2)

Antibiotic visualization tool

EXPERIMENTAL

Provider will answer microbiological sensitivity questions using a new antibiotic visualization tool.

Other: Visualization tool

Standard practice

NO INTERVENTION

Provider will answer microbiological sensitivity questions using standard medical record tools.

Interventions

Visualization tool OTHER

Visual representation of past microbiological culture data

Antibiotic visualization tool

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• provider is caring for a patient with a previous positive urine or blood cultures
• provider is caring for a patient currently in a clinical location being investigated
• provider is caring for a patient with orders placed for an intravenous, intramuscular, oral antibiotics

You may not qualify if:

• the patient has already received the antibiotic by the time of the intervention
• the antibiotic has been cancelled by the time of intervention
• the research assistant is unable to reach the ordering provider before the visit is completed
• participation by the clinician in the study would impede clinical care
• age \< 18

Sponsors & Collaborators

• Beth Israel Deaconess Medical Center: lead

Study Sites (1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States

Location

MeSH Terms

Conditions

Communicable Diseases

Condition Hierarchy (Ancestors)

Infections; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Steven Horng, MD

  Beth Israel Deaconess Medical Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: April 9, 2018
• First Posted: July 9, 2018
• Study Start: March 5, 2018
• Primary Completion: September 30, 2018
• Study Completion: September 30, 2018
• Last Updated: May 6, 2021

Record last verified: 2021-05

Locations

US (1)